Regulating the advertising of therapeutic goods A legislative - - PowerPoint PPT Presentation

Regulating the advertising of therapeutic goods

A legislative overview

Advertising Education and Assurance Section Regulatory Compliance Branch Regulatory Practice and Support Division

CHP Australia -Therapeutic Goods Advertising Code Seminar

March/April 2020

Before we begin…

You need to know that:

• The information in this session is not

comprehensive

• You should not rely on this

presentation to determine the compliance of your advertising

• The content is not binding on the TGA

We have assumed that:

• You are familiar with the Poisons

Standard and scheduling of medicines

• You know how to locate the

Therapeutic Goods Act and Advertising Code

• You have a basic level of knowledge

about the Code

• You know the definitions for

‘therapeutic good’ and ‘therapeutic use’

1

Three levels of advertising controls

• Legislation administered by

the TGA

Regulation

• Advertising pre-approvals

(shared with industry)

Co-regulation

• Industry Codes

Self-regulation

2

Therapeutic goods advertising legislation

• –

– –

• The advertising requirements are set out in the:

Therapeutic Goods Act Therapeutic Goods Regulations Therapeutic Goods Advertising Code Advertising is also subject to the Competition and Consumer Act (Australian Consumer Law) Australian Health Practitioner Regulation Agency law may also apply

3

Therapeutic Goods Act 1989

4

Definition of ‘advertise’ – s.3 of the Act

“... includes make any statement, pictorial representation or design that is intended, whether directly or indirectly, to promote the use or supply of the goods, including where the statement, pictorial representation or design: (a) is on the label of the goods; or (b) is on the package in which the goods are contained; or (c) is on any material included with the package in which the goods are contained.” Very broad definition Captures advertising irrespective of the medium (e.g. online, print, TV, radio)

5

The therapeutic goods advertising requirements

• –

–

• –

– – The advertising requirements are specified in the form of criminal offence and civil penalty provisions in the Act Offences specific to particular types of therapeutic goods General advertising offences The TGA doesn’t necessarily take court action against advertising that contravenes these offences – we may use other tools: Administrative tools – cancellation/suspension from ARTG Compliance tools Enforcement tools

6

Key advertising offence provisions

Audience Type of good Offence for Criminal offence Civil penalty

Any (including health profs)

Medicines, OTGs Promoting off-label use ss.22(2), (3) & (5) ss.21B(4) Biologicals Promoting off-label use ss.32BJ(2A)-(4) s.32BL Devices Promoting off-label use s.42ML s.41MLB

Consumers

• nly

All Pre-approval offences s.42C N/A All General advertising offences s.42DL s.42DLB All Non-compliance with Code s.42DM s.42DMA

7

Section 42DL – prohibits advertisements:

• for prescription medicines

for biologicals for illegal (unapproved) products with prohibited representations that have not been permitted by the TGA with restricted representations that have not been permitted by the TGA with government endorsement, references to the Act

The Act – general advertising offence

8

Rationale for the Advertising Code

• Therapeutic goods advertising legislation goes beyond the legal requirements for

advertising ordinary consumer goods – because: they are not ordinary goods consumers seeking a therapeutic good may be vulnerable due to a health condition or concerns about a possible health condition The Code exists so that advertisements: are truthful and give consumers adequate information on risks and cautions to enable informed health choices promote only the safe and proper use of therapeutic goods is ethical and does not mislead or deceive the consumer or create unrealistic expectations about product performance

9

Therapeutic Goods Advertising Code

• –

– – –

• –

– – – Advertising must: be accurate, balanced & verified not mislead nor arouse unwarranted expectations not lead to self diagnosis and/or inappropriate treatment must match the indications for the product Other specific requirements include: must not advertise goods as ‘safe’, miraculous no endorsements by health professionals or government must not imply that other goods are harmful or ineffectual certain mandatory statements must be included

10

Prohibited and Restricted Representations

11

Prohibited representations

• :

– – – –

• Representations specified in (or through) the Regulations

Any representation regarding the treatment, cure, prevention, diagnosis (including screening), monitoring or susceptibility of, or pre-disposition to, the following diseases Neoplastic diseases Sexually Transmitted Diseases (STD) HIV AIDS and/or Hepatitis C viruses Mental illness Abortifacient action claims Other claims – including for antiseptics & disinfectants

Legislative definition: see s.42DJ of Act, read with Regulation 6B & Part 1

• f Schedule 2 of the Regulations and

s.30 of the Code

12

Restricted representations

• Restricted representations must be approved or permitted by the TGA before

being used in an advertisement A representation in advertising that refers, expressly or by implication, to a serious form of a disease, condition, ailment or defect, as defined in s.28 of the Code, needs prior approval Note exclusions for uncomplicated pregnancy and conditions that can be self-managed post-diagnosis Legislative definition: see s.42DD of the Act, read with s.28 of the Code

13

Applying for approval to use a restricted representation

• ‒

‒

• Legislative requirements for applications:

Set out in sections 42DD to s.42DK Includes the criteria TGA use to decide whether to approve an application New online form contains checklists Frame your application to address the criteria the TGA have to assess Guidance and approvals also available on website - www.tga.gov.au/form/application- approval-use-restricted-representation-advertising

14

Unapproved prohibited and restricted representations - possible consequences

• 2. Cease making claims or represtntations for Gumby Gumby capsules outright or in the form of testimonials

that:

• i. They have or may have an effect on cancer of any sort, location or grade;
• ii. They have or may have an effect on arthritis, chronic fatigue syndrome, or skin diseases.
• iii. The have or may have any other therapeutic use whatsoever while ever the capsules are not included in

the Australia Register of Therapeutic Goods (ARTG);

• iv. You can or are able to arrance the supply of these therapeutic goods which are not included in the ARTG

and not excluded or exempted from that requirement. See - https://www.tga.gov.au/direction-about-advertisement-gumby-gumby-capsules

15

Interface issues: services, foods, cosmetics and consumer goods

16

Interfaces with therapeutic goods regulation

• The TGA does not ordinarily regulate the supply, provision or advertising of:

Health services Foods Cosmetics Consumer goods The way these things are promoted could result in the advertising or products being captured under the therapeutic goods legislation

17

The definition of “therapeutic goods” EXCLUDES –

• ‒

‒ goods declared by the TGA to NOT be therapeutic goods; or foods for which: there is a prescribed standard in ANZ Food Standards Code, or there is a tradition of use in ANZ as foods in the form in which they are presented

Interface Issues - overview

18

Interface issues: Foods Food

• r therapeutic

good?

19

Food - Medicine interface guidance tool

• Search “food medicine interface guidance

tool” on TGA website

20

• –
• ‒

‒

• Cosmetics are regulated under legislation administered by the National

Industrial Chemicals Notification & Assessment Scheme: the Industrial Chemical Notification Act 1990 (ICNA Act) A cosmetic: must meet the definition of “cosmetic” in the ICNA Act cannot be a ‘therapeutic good’ within the meaning of the Therapeutic Goods Act 1989 i.e. must not be for preventing, diagnosing, curing or alleviating a disease, ailment, defect or injury in persons

Interface issues - Cosmetics

21

Interface issues – Cosmetics

https://www.nicnas.gov.au/cosmetics-and-soaps/is-my-product-a-cosmetic

22

Interface issues - Cosmetic products

23

Interface issues – Consumer products

24

Some top tips…

 Check if your advertisements need approvals

 Ensure claims are consistent with indications/intended purpose in ARTG  Before advertising – is it a therapeutic good…or something else?  Don’t advertise with prohibited or unapproved restricted representations

25

TGA’s advertising complaints handling: framework and insights

Our approach to handling complaints

• –

– – – Our approach is published on the TGA website: https://www.tga.gov.au/publication/complaints-handling-advertising-therapeutic-goods- australian-public Some key principles: We focus resources on alleged non-compliance with highest public safety risks We consider the perceptions of & impact on ‘reasonable consumer’ when assessing advertising Compliance/enforcement actions are evidence-based and depend on the types of behaviours identified, including willingness of advertiser to be compliant Our processes support consistent compliance and enforcement outcomes and provide clarity for the public and advertisers

27

What’s in our compliance toolkit?

Voluntary compliance

• Education program (further information about this later in the afternoon)

Enquiry services Advertising pre-approvals remain until June 2020 Assisted compliance Obligations Notice – informs advertisers their advertising may not be compliant and advises them of their obligations Warning - informs advertisers their advertising is non-compliant and advises them of regulatory action that may be taken if they fail to respond/comply – requires a written response

28

What’s in our compliance toolkit? (2)

Regulatory Compliance

• Substantiation Notice

Directions Notice Cancellation or suspension of the therapeutic good from the ARTG Public Warning Notice Injunction from the Federal Court or Federal Circuit Court Infringement Notice Enforceable Undertaking Prosecution of a civil penalty provision Referral to the Commonwealth Director of Public Prosecutions for criminal prosecution

29

Trends in compliance

• –

– – –

• For the period 1 October 2019 – 31 December 2019

87% of the 358 complaints received were about advertising in social media and web-based platforms 1,233 products featured in advertising complaints in this period – medicines (40%), medical devices (15%) and not on the ARTG (45%) 79% of all cases were categorised as ‘low’; the remainder were ‘medium’ and ‘high’ Of the ‘medium’ cases the following themes were identified: Weight loss products, hangover products, memory enhancement (Ginkgo biloba), Benign prostatic hypertrophy (Saw Palmetto), muscle cramps (magnesium), heart health (CoQ10) and pain relief devices. Coronavirus is an emerging issue – note published web statement

30

Top tips to prevent compliance action

 Be contactable by the TGA

 If you receive correspondence from the TGA, read it  Reply to TGA correspondence within specified timeframe  Have robust procedures in your business for dealing with correspondence and checking advertising compliance  Address compliance issues expeditiously  Don’t wait for a complaint to collate supporting evidence for ads

31

The benefits of compliant advertising

• A robust and effective system of advertising controls

Promotes responsible advertising Reinforces quality use of therapeutic goods Supports consumer confidence and trust Enhances health outcomes for all Australians Level playing field for business

32

Further information

We provide tools to assist advertisers and in managing their compliance, including:

• –

– – –

• On the advertising hub: https://www.tga.gov.au/advertising-hub

Australian Regulatory Guidelines on Advertising Therapeutic Goods Code guidance Fact sheets and decision trees Presentations from seminars Facebook, Twitter, Instagram Advertising mailing list

• Contact:

advertising.education@tga.gov.au

33